Clinical trial
Incidence and Risk Factors for Invasive Mold Infections in Children During First-Line Chemotherapy for Primary Acute Leukemia: Protocol for a National Retrospective Cohort Study
NCT05774990 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence and Risk Factors for Invasive Mold Infections in Children During First-Line Chemotherapy for Primary Acute Leukemia: Protocol for a National Retrospective Cohort Study
- Lead sponsor
- University of Southern Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2023
- Completion date
- October 26, 2025
- Enrollment
- 621 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia, leukemia, myeloid, acute